Orbimed Advisors LLC’s Relmada Therapeutics Inc Position
Does Orbimed Advisors LLC own Relmada Therapeutics Inc (RLMD)? Yes — 4.72M shares worth $33M (+0.65% of its 13F portfolio) as of Q1 2026, up from 2.61M shares the prior filed quarter.
Position Value
$33M
Q1 2026
Shares
4.72M
% of Portfolio
+0.65%
Quarters Held
2
currently held
Position History RLMD
Reported value by quarter
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Orbimed Advisors LLC’s full portfolio or all institutional holders of RLMD.